 |  |
| ABX | ||
| 2,843.312 | ||
| 2,843.3120 | 0.0000% | |
| BISNIS-27 | ||
| 562.278 | ||
| 562.2780 | 0.0000% | |
| DBX | ||
| 4,411.268 | ||
| 4,411.2680 | 0.0000% | |
| ECONOMIC30 | ||
| 119.528 | ||
| 119.5280 | 0.0000% | |
| ESGQKEHATI | ||
| 128.156 | ||
| 128.1560 | 0.0000% | |
| ESGSKEHATI | ||
| 129.037 | ||
| 129.0370 | 0.0000% | |
| I-GRADE | ||
| 229.103 | ||
| 229.1030 | 0.0000% | |
| AUDRP | ||
| 11,285.430 | ||
| -4.0900 | -0.0362% | |
| EURRP | ||
| 19,575.490 | ||
| -7.2600 | -0.0371% | |
| JPYRP | ||
| 106.815 | ||
| -0.1158 | -0.1083% | |
| SINRP | ||
| 13,066.120 | ||
| -13.5100 | -0.1033% | |
| USDRP | ||
| 16,739.000 | ||
| -16.0000 | -0.0955% | |
Helus Pharma builds on the strong foundation originally created as Cybin Inc., reflecting the Company’s ongoing transformation to a commercial stage pharmaceutical company Falcon H1R 7B Packs Advanced Reasoning into a Compact 7 Billion Parameter Model Optimized for Speed and EfficiencyBerita Terbaru
HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq
TII Launches Falcon Reasoning: Best 7B AI Model Globally, Also Outperforms Larger Models
Market Summary
CODE LAST +/- % CODE LAST +/- % Time CODE LAST +/- % 
